1,153
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Flavone-based dual PARP-Tubulin inhibitor manifesting efficacy against endometrial cancer

, , , , , , , , , , & show all
Article: 2276665 | Received 08 Jul 2023, Accepted 24 Oct 2023, Published online: 02 Nov 2023

Reprints and Permissions

This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.

You are not required to obtain permission to reuse this article in part or whole.